Sanford Burnham Prebys expands collaboration with Lilly to investigate immunological therapies

Sanford Burnham Prebys Medical Discovery Institute today announced a three-year extension to its existing collaboration with Eli Lilly and Company (Lilly) to discover and develop immunological therapies.

Click to view original post